Annual report pursuant to Section 13 and 15(d)

Schedule I - Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)

v3.22.0.1
Schedule I - Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities $ 2,469 $ 1,265 $ 1,833
Cash flows from investing activities      
Property, plant and equipment (966) (1,839) (3,056)
Net cash used in investing activities (912) (1,947) (3,163)
Cash flows from financing activities      
Proceeds from issuances of debt 5,911 7,823 6,434
Redemptions and repayments of debt (6,810) (6,940) (4,346)
Debt issuance and other financing costs (53) (125) (51)
Debt modification or extinguishment costs (82) (172) (15)
Cash dividends to shareholders (85) 0 0
Distributions to non-controlling interest (649) (626) (590)
Payments related to tax withholdings for share-based compensation (48) (43) (19)
Repurchase of common stock (9) (155) (249)
Net cash provided by (used in) financing activities (1,817) (235) 1,168
Net decrease in cash, cash equivalents and restricted cash and cash equivalents (260) (917) (162)
Cash, cash equivalents and restricted cash and cash equivalents—beginning of period 2,077 2,994 3,156
Cash, cash equivalents and restricted cash and cash equivalents—end of period 1,817 2,077 2,994
Condensed Cash Flow Statement - Balances per Condensed Balance Sheet [Line Items]      
Cash and cash equivalents 1,404 [1] 1,628  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1,817 2,077 2,994
Cheniere [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities (232) (285) 74
Cash flows from investing activities      
Property, plant and equipment (6) (13) (2)
Distribution from (investment in) subsidiaries 1,498 (481) 842
Net cash used in investing activities 1,492 (494) 840
Cash flows from financing activities      
Proceeds from issuances of debt 1,579 4,778 0
Redemptions and repayments of debt (2,022) (3,143) 0
Debt issuance and other financing costs (9) (57) 0
Debt modification or extinguishment costs (1) (29) 0
Cash dividends to shareholders (85) 0 0
Distributions to non-controlling interest (649) (626) (591)
Payments related to tax withholdings for share-based compensation (48) (43) (19)
Repurchase of common stock (9) (155) (249)
Net cash provided by (used in) financing activities (1,244) 725 (859)
Net decrease in cash, cash equivalents and restricted cash and cash equivalents 16 (54) 55
Cash, cash equivalents and restricted cash and cash equivalents—beginning of period 1 55 0
Cash, cash equivalents and restricted cash and cash equivalents—end of period 17 1 55
Condensed Cash Flow Statement - Balances per Condensed Balance Sheet [Line Items]      
Cash and cash equivalents 17 0  
Restricted cash and cash equivalents 0 1  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 17 $ 1 $ 55
[1] Amounts presented include balances held by our consolidated variable interest entity (“VIE”), CQP, as further discussed in Note 9—Non-controlling Interest and Variable Interest Entity. As of December 31, 2021, total assets and liabilities of CQP, which are included in our Consolidated Balance Sheets, were $19.0 billion and $18.6 billion, respectively, including $0.9 billion of cash and cash equivalents and $0.1 billion of restricted cash and cash equivalents.